BROCHURES For more information, select the type of brochure: GENERAL, GENERICS, COSMETICS or INDIVIDUALIZED PEPTIDES Enter your details below and you will receive a free download link. Company* Country* Name* Email* Type of brochure General Generics Cosmetics Individualized Peptides Message CAPTCHA I consent to the collection and storage of data for the purpose of processing my request as part of my contact. The information collected from this form is recorded and transmitted to the staff of our company responsible for processing your message. See our privacy policy You have a right of access, rectification and opposition to the data concerning you, which you can exercise by going to this page: Contact the Personal Data Protection Officer Brochures History Innovation and Technology Management People at Polypeptide Sustainability Videos Vision PEOPLE AT POLYPEPTIDE SALES TEAM EUROPE SALES TEAM USA POLYPEPTIDE GROUP INFO INVESTORS CORPORATE NEWS OUR STORIES ABOUT US MEDIA CONTACT CONTACT US QUOTATION REQUEST CAREERS SOCIALS LINKEDIN FACEBOOK TWITTER YOUTUBE © Confidentiality 2021 PolyPeptide Group • Cookie management • Personal data • Sitemap ACTH (1-39) PorcineAtosibanCalcitoninCarbetocinDeslorelinDesmopressinExenatideFelypressinLeuprolideLiraglutideOctreotidePTH (1-34) TeriparatideSemaglutideSomatostatinTriptorelinVasopressin, 8-L-Arginine By clicking “Accept”, you consent to the use of ALL the cookies on our website . However you may visit Cookie Settings to provide a controlled consent. Cookie settingsACCEPT

COVID-19 Outbreak Information – Click here for the latest updates INVESTORS Interactive Share Price Chart PolyPeptide Group is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one-half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 900 employees, its diversity brings breadth, depth of knowledge and experience to the group. PolyPeptide has grown organically and by selective acquisition of existing expertise, culminating in its position today as a leader in outsourced peptide manufacturing. PolyPeptide’s shares (PPGN) are listed on the Swiss Stock Exchange SIX. INVESTORS Share Information Corporate News Analyst Coverage Results Center Corporate Calendar Presentations Corporate Governance Initial Public Offering IR Contact ABOUT US HISTORY INNOVATION & TECHNOLOGY OUR STORIES BROCHURES VIDEOS POLYPEPTIDE GROUP INFO INVESTORS CORPORATE NEWS OUR STORIES ABOUT US MEDIA CONTACT CONTACT US QUOTATION REQUEST CAREERS SOCIALS LINKEDIN FACEBOOK TWITTER YOUTUBE © Confidentiality 2021 PolyPeptide Group Cookie management Personal data Sitemap ACTH (1-39) Porcine Atosiban Calcitonin Carbetocin Deslorelin Desmopressin Exenatide Felypressin Leuprolide Liraglutide Octreotide PTH (1-34) Teriparatide Semaglutide Somatostatin Triptorelin Vasopressin, 8-L-Arginine